A shear gradient-activated microfluidic device for automated monitoring of whole blood haemostasis and platelet function

[1]  I. Kullo,et al.  CLINICAL PRACTICE. Peripheral Artery Disease. , 2016, The New England journal of medicine.

[2]  P. Nguyên,et al.  Anticoagulation in Chronic Hemodialysis: Progress Toward an Optimal Approach , 2015, Seminars in dialysis.

[3]  J. Di Paola,et al.  Microfluidic technology as an emerging clinical tool to evaluate thrombosis and hemostasis. , 2015, Thrombosis research.

[4]  G. Annich.  Extracorporeal life support: the precarious balance of hemostasis , 2015, Journal of thrombosis and haemostasis : JTH.

[5]  D. Ku,et al.  Role of high shear rate in thrombosis. , 2015, Journal of vascular surgery.

[6]  D. Murphy,et al.  Extracorporeal membrane oxygenation-hemostatic complications. , 2015, Transfusion medicine reviews.

[7]  B. Furie,et al.  Defective PDI release from platelets and endothelial cells impairs thrombus formation in Hermansky-Pudlak syndrome. , 2015, Blood.

[8]  T. Lindahl,et al.  Assays of different aspects of haemostasis – what do they measure? , 2015, Thrombosis Journal.

[9]  S. Mallett,et al.  Point‐of‐care monitoring of haemostasis , 2015, Anaesthesia.

[10]  Daniel C Leslie,et al.  A bioinspired omniphobic surface coating on medical devices prevents thrombosis and biofouling , 2014, Nature Biotechnology.

[11]  P. Spinella,et al.  Management of anticoagulation and hemostasis for pediatric extracorporeal membrane oxygenation. , 2014, Clinics in laboratory medicine.

[12]  David N. Ku,et al.  Microfluidic Thrombosis under Multiple Shear Rates and Antiplatelet Therapy Doses , 2014, PloS one.

[13]  D. Dikshit,et al.  Platelets and atherothrombosis: causes, targets and treatments for thrombosis. , 2013, Current medicinal chemistry.

[14]  D. Ku,et al.  A low-volume, single pass in-vitro system of high shear thrombosis in a stenosis. , 2013, Thrombosis research.

[15]  Andrew T. Irish,et al.  Sources of Variability in Platelet Accumulation on Type 1 Fibrillar Collagen in Microfluidic Flow Assays , 2013, PloS one.

[16]  Albert van den Berg,et al.  Atherosclerotic geometries exacerbate pathological thrombus formation poststenosis in a von Willebrand factor-dependent manner , 2013, Proceedings of the National Academy of Sciences.

[17]  J. Heemskerk,et al.  Monitoring in vitro thrombus formation with novel microfluidic devices , 2012, Platelets.

[18]  C. Muir,et al.  Development of a perfusion chamber assay to study in real time the kinetics of thrombosis and the antithrombotic characteristics of antiplatelet drugs , 2012, Thrombosis Journal.

[19]  A. Wiles,et al.  Hemolytic and thrombocytopathic characteristics of extracorporeal membrane oxygenation systems at simulated flow rate for neonates* , 2012, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[20]  I. Maruyama,et al.  A novel automated microchip flow‐chamber system to quantitatively evaluate thrombus formation and antithrombotic agents under blood flow conditions , 2011, Journal of thrombosis and haemostasis : JTH.

[21]  Paul J. Harrison,et al.  Guidelines for the laboratory investigation of heritable disorders of platelet function , 2011, British journal of haematology.

[22]  Abhishek Jain,et al.  Biomimetic postcapillary expansions for enhancing rare blood cell separation on a microfluidic chip. , 2011, Lab on a chip.

[23]  B. Cooley.  In Vivo Fluorescence Imaging of Large-Vessel Thrombosis in Mice , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[24]  J. Olin,et al.  Peripheral artery disease. Part 1: clinical evaluation and noninvasive diagnosis , 2011, Nature Reviews Cardiology.

[25]  W. Voelckel,et al.  Thromboelastometry (TEM®) Findings in Disseminated Intravascular Coagulation in a Pig Model of Endotoxinemia , 2011, Molecular medicine.

[26]  B. Kirby.  Micro- and nanoscale fluid mechanics : transport in microfluidic devices , 2010 .

[27]  S. Nair,et al.  Tests of global haemostasis and their applications in bleeding disorders , 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

[28]  William L Whittier,et al.  Surveillance of Hemodialysis Vascular Access , 2009, Seminars in interventional radiology.

[29]  Arnan Mitchell,et al.  A shear gradient–dependent platelet aggregation mechanism drives thrombus formation , 2009, Nature Medicine.

[30]  C. Hofer,et al.  Coagulation Monitoring: Current Techniques and Clinical Use of Viscoelastic Point-of-Care Coagulation Devices , 2008, Anesthesia and analgesia.

[31]  G. Lowe.  Common risk factors for both arterial and venous thrombosis , 2008, British journal of haematology.

[32]  Shaun P Jackson,et al.  The growing complexity of platelet aggregation. , 2007, Blood.

[33]  A. Ejaz,et al.  Extracorporeal circuit pressure profiles during continuous venovenous haemofiltration. , 2007, Nursing in critical care.

[34]  Y. Son,et al.  Determination of shear viscosity and shear rate from pressure drop and flow rate relationship in a rectangular channel , 2007 .

[35]  Aaron L. Fogelson,et al.  Coagulation under Flow: The Influence of Flow-Mediated Transport on the Initiation and Inhibition of Coagulation , 2006, Pathophysiology of Haemostasis and Thrombosis.

[36]  M. Sitkovsky,et al.  Model organisms: Animal Models of sepsis: setting the stage , 2005, Nature Reviews Drug Discovery.

[37]  A. Michelson.  Platelet function testing in cardiovascular diseases. , 2004, Circulation.

[38]  G. Lippi,et al.  Effect of specimen collection on routine coagulation assays and D-dimer measurement. , 2004, Clinical chemistry.

[39]  M. Greaves,et al.  Role of coagulation testing in predicting bleeding risk. , 2003, The hematology journal : the official journal of the European Haematology Association.

[40]  S. Bajaj,et al.  New Insights into How Blood Clots: Implications for the Use of APTT and PT as Coagulation Screening Tests and in Monitoring of Anticoagulant Therapy , 1999, Seminars in thrombosis and hemostasis.

[41]  G. Whitesides,et al.  Rapid Prototyping of Microfluidic Systems in Poly(dimethylsiloxane). , 1998, Analytical chemistry.

[42]  J. Hirsh,et al.  Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. , 1992, Chest.

[43]  R. Swartz,et al.  Severe Clotting During Extracorporeal Dialysis Procedures , 1991 .

[44]  Y. Cho,et al.  Effects of the non-Newtonian viscosity of blood on flows in a diseased arterial vessel. Part 1: Steady flows. , 1991, Biorheology.

[45]  H. Goldsmith,et al.  Adenosine diphosphate-induced aggregation of human platelets in flow through tubes. II. Effect of shear rate, donor sex, and ADP concentration. , 1989, Biophysical journal.

[46]  U. Abildgaard,et al.  Heparin Assays and Bleeding Complications in Treatment of Deep Venous Thrombosis with Particular Reference to Retroperitoneal Bleeding , 1985, Thrombosis and Haemostasis.

[47]  J. Crawford,et al.  Setting the stage. , 2021, The New England journal of medicine.